213 related articles for article (PubMed ID: 12752119)
1. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin.
Saridaki Z; Liloglou T; Zafiropoulos A; Koumantaki E; Zoras O; Spandidos DA
Br J Dermatol; 2003 Apr; 148(4):638-48. PubMed ID: 12752119
[TBL] [Abstract][Full Text] [Related]
2. High frequency of loss of heterozygosity on chromosome region 9p21-p22 but lack of p16INK4a/p19ARF mutations in greek patients with basal cell carcinoma of the skin.
Saridaki Z; Koumantaki E; Liloglou T; Sourvinos G; Papadopoulos O; Zoras O; Spandidos DA
J Invest Dermatol; 2000 Oct; 115(4):719-25. PubMed ID: 10998150
[TBL] [Abstract][Full Text] [Related]
3. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
4. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
5. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers.
Pacifico A; Goldberg LH; Peris K; Chimenti S; Leone G; Ananthaswamy HN
Br J Dermatol; 2008 Feb; 158(2):291-7. PubMed ID: 18070208
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
Kanellou P; Zaravinos A; Zioga M; Spandidos DA
Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
[TBL] [Abstract][Full Text] [Related]
7. Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer.
Holmberg E; Rozell BL; Toftgård R
Br J Cancer; 1996 Jul; 74(2):246-50. PubMed ID: 8688329
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis.
Kubo Y; Urano Y; Yoshimoto K; Iwahana H; Fukuhara K; Arase S; Itakura M
J Invest Dermatol; 1994 Apr; 102(4):440-4. PubMed ID: 8151121
[TBL] [Abstract][Full Text] [Related]
9. Allelic imbalance studies of chromosome 9 suggest major differences in chromosomal instability among nonmelanoma skin carcinomas.
Gomes GP; Moraes AM; Stoff HO; Ward LS
Sao Paulo Med J; 2004 Jan; 122(1):18-21. PubMed ID: 15160522
[TBL] [Abstract][Full Text] [Related]
10. p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light.
Takata M; Rehman I; Rees JL
Int J Cancer; 1997 May; 71(3):370-2. PubMed ID: 9139870
[TBL] [Abstract][Full Text] [Related]
11. Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cell Mol Med; 2006; 10(3):778-88. PubMed ID: 16989737
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
Reifenberger J; Wolter M; Knobbe CB; Köhler B; Schönicke A; Scharwächter C; Kumar K; Blaschke B; Ruzicka T; Reifenberger G
Br J Dermatol; 2005 Jan; 152(1):43-51. PubMed ID: 15656799
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutations in skin cancers with underlying disorders.
Kanekura T; Kanzaki T; Kanekura S; Kawahara K; Nakashima T; Kitajima I; Maruyama I
J Dermatol Sci; 1995 May; 9(3):209-14. PubMed ID: 8664219
[TBL] [Abstract][Full Text] [Related]
14. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report.
Chuang TY; Reizner GT; Elpern DJ; Stone JL; Farmer ER
J Am Acad Dermatol; 1995 Sep; 33(3):422-6. PubMed ID: 7657865
[TBL] [Abstract][Full Text] [Related]
15. High frequency of DNA aneuploidy detected by DNA flow cytometry in Bowen's disease.
Kawara S; Takata M; Takehara K
J Dermatol Sci; 1999 Sep; 21(1):23-6. PubMed ID: 10468188
[TBL] [Abstract][Full Text] [Related]
16. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
17. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
18. High frequency of CDKN2A alterations in esophageal squamous cell carcinoma from a high-risk Chinese population.
Hu N; Wang C; Su H; Li WJ; Emmert-Buck MR; Li G; Roth MJ; Tang ZZ; Lu N; Giffen C; Albert PS; Taylor PR; Goldstein AM
Genes Chromosomes Cancer; 2004 Mar; 39(3):205-16. PubMed ID: 14732922
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin.
Campbell C; Quinn AG; Ro YS; Angus B; Rees JL
J Invest Dermatol; 1993 Jun; 100(6):746-8. PubMed ID: 8496613
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
